123. The method of any of claims 74-122, wherein the disease or condition is a myeloma, leukemia or lymphoma.
90. The method of any of claims 85-88, wherein the threshold level is within 25%, within 20%, within 15%, within 10% or within 5% and/or is within a standard deviation below the median or mean level, amount or concentration, or is or is about the median or mean level, amount or concentration, of the analyte in a biological sample obtained from a group of subjects prior to receiving a cell therapy, wherein each of the subjects of the group went on to achieve a durable response after administration of a recombinant-receptor-expressing therapeutic cell composition for treating the same disease or condition. In some embodiments of any of the provided articles of manufacture, the instructions specify the administration of the cell therapy is for a subject that is or has been identified as having a double/triple hit lymphoma (or high-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements with DLBCL histology (double/triple hit)), is or has been identified as having a chemorefractory lymphoma, optionally a chemorefractory DLBCL; and/or that has not achieved complete remission (CR) in response to a prior therapy.

Hello, I enjoy reading all of your post. I wanted to write a little comment to support you.

say thanks to a lot for your site it assists a lot.cheap hockey jerseys free shippinghttps://uniform-wiki.win/index.php?title=Plenty_of_perfect_counsell ing_at_lessons_being_young_football_985125447&oldid=336933http://forest xfmwm.mee.nu/?entry=3195472

You've very good information on this website.

I treasure the details on your internet site.
Thanks a bunch.

Love tһe website-- rеally սser friendly and whоle lօtѕ tо sеe!

Wow, gorgeous portal. Thnx ...

Passion the site-- extremely individual pleasant and whole lots to see!

Many thanks very practical. Will share site with my pals.

You're a really useful web site; could not make it without ya!